Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.62 |
| ▸ | NOS2 | P35228 | 6/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 5/20 | 0.43 |
| ▸ | NOS3 | P29474 | 4/20 | 0.43 |
| ▸ | DDAH1 | O94760 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ARG2 | P78540 | 4/20 | 0.43 |
| ▸ | ARG1 | P05089 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ornithine Aketoglutarate SCHEMBL2178954 | 0.98 | GSR (0.64) | GSRNOS2CYP2C19CYP1A2TSHR | |
| Lysine SCHEMBL6561904 | 0.93 | GSR (0.74) | GSRNOS2CYP2C19CYP1A2TSHR | |
| Lysine SCHEMBL27645682 | 0.93 | GSR (0.74) | GSRNOS2CYP2C19CYP1A2TSHR | |
| Ornithine Aketoglutarate SCHEMBL6883619 | 0.92 | GSR (0.53) | GSRNOS2CYP2C19CYP1A2TSHR | |
| Lysine SCHEMBL28112654 | 0.91 | GSR (0.71) | GSRNOS2CYP2C19CYP1A2TSHR | |
| Lysine SCHEMBL28112652 | 0.91 | GSR (0.71) | GSRNOS2CYP2C19CYP1A2TSHR | |
| Ornithine Aketoglutarate SCHEMBL10406134 | 0.86 | GSR (0.82) | GSRNOS2CYP2C19CYP1A2TSHR | |
| D-Ornithine SCHEMBL10406136 | 0.86 | GSR (0.82) | GSRNOS2CYP2C19CYP1A2TSHR | |
| Ornithine SCHEMBL15904598 | 0.84 | GSR (0.78) | GSRNOS2CYP2C19CYP1A2TSHR | |
| Ornithine SCHEMBL3952790 | 0.84 | GSR (0.78) | GSRNOS2CYP2C19CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050129769-A1 | Polymeric articles for carrying therapeutic agents | ALNIS BIOSCIENCES, INC. | 2005-06-16 | — | — | US | disclosed |
| EP-1531868-A2 | THERAPEUTIC AGENT-CONTAINING POLYMERIC NANOARTICLES | Alnis Biosciences, Inc. (US) | 2005-05-25 | — | — | EP | disclosed |
| WO-2005027873-A2 | THERAPEUTIC AMINOGLYCOSIDE-CONTAINING HYDROGEL NANOPARTICLES | ALNIS BIOSCIENCES, INC. (US) | 2005-03-31 | — | — | WO | disclosed |
| US-20040126900-A1 | High affinity peptide- containing nanoparticles | ALNIS BIOSCIENCES INC. | 2004-07-01 | — | — | US | disclosed |
| US-20040058006-A1 | High affinity nanoparticles | ALNIS BIOSCIENCES, INC. | 2004-03-25 | — | — | US | disclosed |
| WO-2003101425-A2 | THERAPEUTIC AGENT-CONTAINING POLYMERIC NANOARTICLES | ALNIS BIOSCIENCES, INC. (US) | 2003-12-11 | — | — | WO | disclosed |
| US-6217901-B1 | POLYMERIZING POLYMER AND LIPOSOMES | ALNIS, LLC | 2001-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050129769-A1 | Polymeric articles for carrying therapeutic agents | CD44, EPCAM, CLTB | GSR 1597/4885NOS2 2399/4885CYP2C19 4881/4885 |
| US-20040126900-A1 | High affinity peptide- containing nanoparticles | LNPEP, IAPP, ACP1 | GSR 4378/4885NOS2 2434/4885CYP2C19 4878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.